Date- TBD
Time- TBD
Exhibit Hall Theater 2
Presented by Phillips Medisize
As IVD technologies advance, the challenge of scaling up manufacturing of complex devices has become more pronounced. This presentation examines how the structure and quality of CDMO collaboration can materially influence success, whether a project is at the earliest concept stage or encountering friction when moving from low-volume builds to high-volume manufacture.
Drawing on examples from complex IVD builds, the presentation will explore how strong, well-structured collaboration helps shape how specifications are developed, risks are managed and scale-up decisions are made. From the perspective of a CDMO in a privately held organization, the presentation also considers how Phillips Medisize’ s private ownership within Molex and Koch enables long-term commitments and the ability to commit resources where programs create shared value, and how access to a broad network of capabilities and business relationships helps programs address commercialization challenges.
Gain a clear, practical view of what effective collaboration looks like in real projects across the project life cycle
How it enables repeatable execution at scale
How to recognize working relationships that are built to perform
Rich Jones
Vice President, Global IVD and Life Sciences,
Phillips Medisize
Pradnya Parulekar
Associate Director of Business Development,
Phillips Medisize